LLY

1,104.88

-0.74%↓

JNJ

236.93

+2.5%↑

ABBV

234.79

+1.36%↑

UNH

407.58

-0.24%↓

NVS

152.83

+2.49%↑

LLY

1,104.88

-0.74%↓

JNJ

236.93

+2.5%↑

ABBV

234.79

+1.36%↑

UNH

407.58

-0.24%↓

NVS

152.83

+2.49%↑

LLY

1,104.88

-0.74%↓

JNJ

236.93

+2.5%↑

ABBV

234.79

+1.36%↑

UNH

407.58

-0.24%↓

NVS

152.83

+2.49%↑

LLY

1,104.88

-0.74%↓

JNJ

236.93

+2.5%↑

ABBV

234.79

+1.36%↑

UNH

407.58

-0.24%↓

NVS

152.83

+2.49%↑

LLY

1,104.88

-0.74%↓

JNJ

236.93

+2.5%↑

ABBV

234.79

+1.36%↑

UNH

407.58

-0.24%↓

NVS

152.83

+2.49%↑

Search

Insulet Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

144.04 2.4

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

138.44

Max

145.41

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-11M

91M

Pardavimai

-22M

762M

P/E

Sektoriaus vid.

34.612

49.712

Pelnas, tenkantis vienai akcijai

1.3

Pelno marža

11.96

Darbuotojai

5,400

EBITDA

-23M

154M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+65.04% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.6B

10B

Ankstesnė atidarymo kaina

141.64

Ankstesnė uždarymo kaina

144.04

Naujienos nuotaikos

By Acuity

32%

68%

68 / 342 reitingas Healthcare

Insulet Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Apie bendrovę Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat